Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors(Stage IA-IB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Early research (Phase 1)Looking for participantsNCT07215637
What this trial is testing

Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Chong Kun Dang Pharmaceutical 60
Early research (Phase 1)UnknownNCT06329206
What this trial is testing

A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Genhouse Bio Co., Ltd. 156
Early research (Phase 1)Looking for participantsNCT05857332
What this trial is testing

SG1906 for CLDN18.2-Positive Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd. 60
Early research (Phase 1)UnknownNCT04708210
What this trial is testing

Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Innovent Biologics (Suzhou) Co. Ltd. 256
Early research (Phase 1)Looking for participantsNCT07368127
What this trial is testing

TPD3310 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Solid Tumors
TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. 112
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Looking for participantsNCT06615193
What this trial is testing

HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorsRefractory LymphomaRelapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 111
Early research (Phase 1)Looking for participantsNCT04997993
What this trial is testing

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

Who this might be right for
PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Deborah Doroshow 23
Early research (Phase 1)Looking for participantsNCT06514651
What this trial is testing

MAQ-001 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
MabQuest SA 30
Early research (Phase 1)UnknownNCT05957471
What this trial is testing

Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Biocity Biopharmaceutics Co., Ltd. 27
Early research (Phase 1)Looking for participantsNCT06302621
What this trial is testing

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+1 more
Massachusetts General Hospital 32
Early research (Phase 1)Active Not RecruitingNCT05460767
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid Tumors or Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 504
Early research (Phase 1)Study completedNCT03449381
What this trial is testing

This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)

Who this might be right for
Neoplasms
Boehringer Ingelheim 266
Early research (Phase 1)Study completedNCT04421352
What this trial is testing

Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients

Who this might be right for
Relapsed Small Cell Lung Cancer
CStone Pharmaceuticals 11
Early research (Phase 1)Active Not RecruitingNCT04973163
What this trial is testing

Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Who this might be right for
Solid Tumors, KRAS Mutation
Boehringer Ingelheim 30
Early research (Phase 1)Looking for participantsNCT07719920
What this trial is testing

A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. 99
Early research (Phase 1)Looking for participantsNCT06548672
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic Solid Tumor
Biocity Biopharmaceutics Co., Ltd. 148
Early research (Phase 1)UnknownNCT05370755
What this trial is testing

ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Who this might be right for
Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd. 22
Early research (Phase 1)Ended earlyNCT06488716
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumour
Genentech, Inc. 12
Next Page